• Core Scientific expects approximately $1.8 billion in average annual recurring GAAP revenue from more than $24 billion in contracted capacity.
• Annual net operating income is projected at approximately $1.6 billion, reflecting a 90% blended margin.
• CoreWeave contracts offer more than $10 billion in revenue potential, including approximately $850 million in average annualized colocation GAAP revenue.
• Anticipated CoreWeave profit margins range from 80% to 85%.
• Full delivery of 530 MW leased to AMD and an AMD-backed neocloud is expected by the end of 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.